Key therapeutic categories
We established our presence in Asia region in 1989 with the launch of our Candid product range in Sri Lanka and today, we rank among the top 21 companies in the country. Glenmark is ranked no. 1 in dermatology therapy and is one of the leading players in respiratory medicine in Sri Lanka.
Our progress led to establishing ourselves further in the region and currently we have successful operations across 14 markets in Asia with a key focus on Philippines, Malaysia, Vietnam, Myanmar and Sri Lanka. We also rank among the top generic companies in Myanmar and Malaysia and enjoy a leadership position in the areas of dermatology, cough management and gastrointestinal segments.
With over 60 products being successfully marketed in this region, our strategy is to focus on power brands that contribute substantially to the overall sales.
Markets The geographies we cater to:
- Sri Lanka